Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine
about
Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatmentParaprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance.Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.Amyloidosis: pathogenesis and new therapeutic options.Primary systemic amyloidosis as a real diagnostic challenge - case study.The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic.A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis.Screening panels for detection of monoclonal gammopathies.Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies.Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach.Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management.How to diagnose amyloidosis.Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions.Immunoglobulin light chain amyloidosis.The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease.Audit of Use and Overuse of Serum Protein Immunofixation Electrophoresis and Serum Free Light Chain Assay in Tertiary Health Care: A Case for Algorithmic Testing to Optimize Laboratory Utilization.Systemic amyloidosis: novel therapies and role of biomarkers.Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions.Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies.Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment.Capillary electrophoresis/immunosubtraction as a better alternative to immunofixation for detecting and immunotyping serum monoclonal proteins in patients with immunoglobulin light chain (AL) amyloidosis.Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis.Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio.Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ RatioQuantitative serum free light chain assay--analytical issues.Screening panels for monoclonal gammopathies: time to changeAmyloidosis: an unusual cause of portal hypertension.Monoclonal gammopathies--clinical and laboratory issues.New concepts in the treatment and diagnosis of amyloidosis.Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure.Urine immunofixation electrophoresis remains important and is complementary to serum free light chain.Oligosecretory Myeloma With Amyloidosis and Alopecia.Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis.Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies: High False-Positive Rate.Light Chain Amyloidosis.AbstractsPrimary Systemic Amyloidosis (AL)Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients
P2860
Q26827340-89B01B7A-3AFE-47BD-ABBB-561C6266BFFEQ30276115-FFEDCAEC-C1AD-4800-A445-82B5BC5C740FQ34448455-C25578B5-C033-4EB9-910E-B7A0D8797FBDQ35012436-BCAC3E5A-3B37-49E0-82EA-AA7EF92F0B52Q35111771-268F1EA8-6FD7-40BB-B98A-980BB6CA69BBQ35631725-FE502B41-D221-4C22-80E7-C841891B2D2EQ36356006-DEF5E028-CC83-4F5B-8647-CFB047CB425DQ36862339-882BDCEC-B299-4DA8-8DCE-F03115F39D41Q37172007-740B4DA9-EAE2-4339-A739-63FC540AD11FQ37370051-EA78B91D-59A9-4C76-B144-868A40435ADFQ37676296-580BC75C-98B0-42B4-A83E-109B2B17CE56Q37821496-F27DDD6E-931C-48B7-83E0-A98459FF74FFQ37832199-21F56F9A-298B-4F4A-8C6F-F59FF5B667C2Q38136289-EE637DEA-D12A-48A4-8149-A20A401E1EE4Q38168869-9F4E56F9-0ABC-41E5-B16E-B15AEC532364Q38172295-BFF59935-1FB6-43A7-9361-07CC474CFA1DQ38258148-3DC9C455-D803-42BA-A5EE-60DDEAD561E1Q38819967-1A9D7905-E6E5-4E4A-BFF4-6863139EFE3EQ38829923-3C7A822B-43E8-48F0-A40A-24D32FA538E4Q38911216-16396A98-1E26-4D3F-9067-4F0761275C72Q38917341-28DFC0A5-14D3-46C2-B2F3-A57C17999533Q38928383-3EE95657-F0B3-4569-B8BC-CAAE1832C88DQ39341586-5E3D0FEF-F044-44C2-88AB-A79971680CB6Q39594256-3C0A374D-A976-4447-9C7D-98235769AF02Q40563598-A8C85F71-48D0-44EF-BD7A-94C7F8CB6DB1Q41896714-FC52583D-145C-44EE-BA72-000F8171668BQ41994443-2C718D05-CA78-4DE8-8AA9-122D6A5FC0F1Q42098619-C5464CE7-4EDB-4FF3-B9E6-14402B5B9EECQ42360655-107B778D-0CAF-4A66-AC80-458CCCC6D773Q42574085-F987F70B-749F-45A1-8103-E929E4F857D8Q47561519-D3F79D8A-BF3D-4DF0-8984-C28A4A758A45Q48629376-FA40F212-9E2F-4165-8D02-CB79E16C2EA8Q48853691-283FE0D0-3F80-43E7-906C-C73F8927CAE0Q49218963-23180A30-85FD-4811-9359-C2FB977BB947Q51039671-B1D31AFC-B8D7-4A7D-A251-677D7FB2DF10Q51606154-5802B7D2-B313-4DCD-85D1-C3FF92247865Q52659305-2CD94176-55C8-4455-811E-14EBC0B8E4FBQ57259399-677399E4-A245-4F38-AEEC-5AC55B832A0EQ57904586-B445141F-A9E4-43C1-946A-35231FD79EC9Q58029880-B0922FE1-0F1E-4503-B568-B0767AFF2834
P2860
Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine
description
im Januar 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 08 January 2009
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2009
@uk
name
Identification of Amyloidogeni ...... unofixation of Serum and Urine
@en
Identification of Amyloidogeni ...... unofixation of Serum and Urine
@nl
type
label
Identification of Amyloidogeni ...... unofixation of Serum and Urine
@en
Identification of Amyloidogeni ...... unofixation of Serum and Urine
@nl
prefLabel
Identification of Amyloidogeni ...... unofixation of Serum and Urine
@en
Identification of Amyloidogeni ...... unofixation of Serum and Urine
@nl
P2093
P50
P1433
P1476
Identification of amyloidogeni ...... unofixation of serum and urine
@en
P2093
Gabriele Sarais
Gabriella Righetti
Gian Vico Melzi D'Eril
Laura Verga
Maddalena Marini
Maria Stella Graziani
Paola Russo
Remigio Moratti
Riccardo Albertini
Simona Casarini
P304
P356
10.1373/CLINCHEM.2008.117143
P407
P577
2009-01-08T00:00:00Z